Elevance Health, Inc.

ELV · NYSE

Elevance reported 2025 revenue of $199.1 billion and first-quarter 2026 revenue of $50.2 billion. The thesis depends on medical-cost control, Medicaid and Medicare trends, commercial pricing, regulation, cash flow and capital allocation.

Follow Add to Watchlist Ask Question

NYSE ELV Coverage Bootstrap Elevance Health, Inc.

Latest ReportMay 19, 2026Elevance Health: managed-care scale meets the medical-cost testView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->

Admin-only preview

Valuation is limited to admins for now.

The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.